federal_register: 2015-10480
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-10480 | Administrative Applications and the Phased Review Process; Guidance for Industry; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry (GFI) #132 entitled "Administrative Applications and the Phased Review Process." This guidance defines the "phased review process" for reviewing application-level information during the investigational period of new animal drug development, and an "administrative" new animal drug application (NADA) or abbreviated new animal drug application (ANADA), the content, the procedures a sponsor should follow to submit such an application, and the intended time frame for its review. | 2015-05-06 | 2015 | 5 | https://www.federalregister.gov/documents/2015/05/06/2015-10480/administrative-applications-and-the-phased-review-process-guidance-for-industry-availability | https://www.govinfo.gov/content/pkg/FR-2015-05-06/pdf/2015-10480.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry (GFI) #132 entitled "Administrative Applications and the Phased Review Process." This guidance defines the "phased review process" for reviewing... |